Most patients treated with systemic therapy received R +/− chlorambucil, and results were in line with published data for gastric MALT lymphoma; however, no difference in ORR or PFS regarding MALT1 status (as previously suggested) was observed [27,28]. Here, MALT1 is linked to gastric mucosa-associated lymphoid tissue lymphoma.